Human Vaccine Adjuvants Market Size And Share

  • Report Code : TIPRE00020517
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 199
Buy Now

Human Vaccine Adjuvants Market Share, Analysis, and Growth by 2031

Buy Now

Human Vaccine Adjuvants Market Report Human Vaccine Adjuvants Market Scope and Analysis Human Vaccine Adjuvants Market Size and Share

Human Vaccine Adjuvants Market: Strategic Insights

Human Vaccine Adjuvants Market

  • CAGR (2022 - 2030)
    14.0%
  • Market Size 2022
    US$ 1,571.41 Million
  • Market Size 2030
    US$ 4,489.23 Million

Market Dynamics

GROWTH DRIVERS
  • Growing focus on immunization is propelling the vaccine production
FUTURE TRENDS
  • Increasing burden of chronic diseases has led to a growing demand for vaccines
OPPORTUNITIES
  • Growing Pharmaceutical Industry Create Lucrative Growth Opportunities

Key Players

  • Novartis AG
  • Dynavax Technologies Corp
  • CSL Ltd
  • SEPPIC SA
  • SPI Pharma Inc
  • Hawaii Biotech Inc
  • Croda International Plc
  • Novavax Inc
  • Phibro Animal Health Corp
  • Creative Biolabs Inc

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Type
  • Particulate Adjuvant
  • Emulsion Adjuvant
  • Combination Adjuvant
Application
  • Influenza
  • Hepatitis
  • Human papilloma virus
End User
  • Pharmaceutical and Biotechnology Companies
  • CMOs and CROs